ONCOZ — Oncozenge AB Balance Sheet
0.000.00%
- SEK35.37m
- SEK25.71m
Annual balance sheet for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | PRESS | ARS | ARS |
Standards: | SAS | — | SAS | SAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 10 | 51.2 | 29.1 | 12.6 |
Net Total Receivables | 5.51 | 0.915 | 0.19 | 0.22 |
Prepaid Expenses | ||||
Total Current Assets | 15.5 | 52.1 | 30 | 13.5 |
Net Property, Plant And Equipment | 0 | — | — | — |
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 38.3 | 85.2 | 36.9 | 20.3 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 9.01 | 4.9 | 2.92 | 1.7 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 9.01 | 4.9 | 2.92 | 1.7 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 29.3 | 80.3 | 34 | 18.6 |
Total Liabilities & Shareholders' Equity | 38.3 | 85.2 | 36.9 | 20.3 |
Total Common Shares Outstanding |